Buscador de publicaciones
Mostrando 1366 a 1380 de 1626 publicaciones.
- Díaz-Infante E, Sitges M, Vidal B, Mont L, Delgado V, Marigliano A, Macías A, Tolosana JM, Tamborero D, Azqueta M, Roig E, Paré C, Brugada J. Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapy.
Am. J. Cardiol. 2007 Jul; 100(1): 84-9
IF: 3.603, Cuartil: 1
- Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badía J, D'Agostino RB. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
J Epidemiol Community Health 2007 Jan; 61(1): 40-7
IF: 3.186, Cuartil: 1
- Angiolillo DJ, Fernández-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
J. Am. Coll. Cardiol. 2007 Apr; 49(14): 1505-16
IF: 11.054, Cuartil: 1, Decil: 1
- Alfonso F, Bermejo J, Segovia J. [Cardiovascular disease in women. Why now?].
Rev Esp Cardiol 2006 Mar; 59(3): 259-63
IF: 2.176, Cuartil: 2
- Delgado V, Sitges M, Andrea R, Rivera S, Masotti M, Francino A, Azqueta M, Paré C, Betriu A. [Clinical and echocardiographic follow-up of patients with hypertrophic obstructive cardiomyopathy treated by percutaneous septal ablation].
Rev Esp Cardiol 2006 Nov; 59(11): 1123-30
IF: 2.176, Cuartil: 2
- Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Rev Esp Cardiol 2006 Apr; 59(4): 313-20
IF: 2.176, Cuartil: 2
- Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, Gómez-Hospital JA, Sanmartín M, Bañuelos C, Moreno R, Escaned J, Fernández C, Costa MA, Fernández-Avilés F, Macaya C. [Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].
Rev Esp Cardiol 2006 Oct; 59(10): 1000-7
IF: 2.176, Cuartil: 2
- Marrugat J, Sala J, Aboal J. [Epidemiology of cardiovascular disease in women].
Rev Esp Cardiol 2006 Mar; 59(3): 264-74
IF: 2.176, Cuartil: 2
- Heras M. [Ischemic heart disease in women: clinical presentation, non-invasive testing and management of acute coronary syndromes].
Rev Esp Cardiol 2006 Apr; 59(4): 371-81
IF: 2.176, Cuartil: 2
- Jiménez-Expósito MJ, Mestres CA, Claramonte X, Cartañá R, Josa M, Pomar JL, Mulet J, Miró JM. [Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study].
Rev Esp Cardiol 2006 Mar; 59(3): 276-9
IF: 2.176, Cuartil: 2
- Alfonso F, Segovia J, Heras M, Bermejo J. [Publication of clinical trials in scientific journals: editorial issues].
Rev Esp Cardiol 2006 Nov; 59(11): 1206-14
IF: 2.176, Cuartil: 2
- Heras M, Marrugat J, Arós F, Bosch X, Enero J, Suárez MA, Pabón P, Ancillo P, Loma-Osorio A, Rodríguez JJ, Subirana I, Vila J. [Reduction in acute myocardial infarction mortality over a five-year period].
Rev Esp Cardiol 2006 Mar; 59(3): 200-8
IF: 2.176, Cuartil: 2
- Alfonso F, Segovia J, Heras M, Bermejo J. [Revista Española de Cardiología 2006: activity, readership, and scientific impact].
Rev Esp Cardiol 2006 Dec; 59(12): 1339-44
IF: 2.176, Cuartil: 2
- Roig E, Pérez-Villa F, Cuppoletti A, Castillo M, Hernández N, Morales M, Betriu A. [Specialized care program for end-stage heart failure patients. Initial experience in a heart failure unit].
Rev Esp Cardiol 2006 Feb; 59(2): 109-16
IF: 2.176, Cuartil: 2
- Bermejo J, Segovia J, Alfonso F. [Summary of the clinical studies reported in the scientific session of the American Heart Association 2005 (Dallas, Texas, USA, 13-16 November 2005)].
Rev Esp Cardiol 2006 Feb; 59(2): 143-53
IF: 2.176, Cuartil: 2
Una iniciativa de
